Paul Emery (P Emery)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 97

Top Topics

Rheumatoid Arthritis

Disease Activity

Magnetic Resonance Imaging

Top Venues

Annals of the rheumatic diseases

Arthritis & rheumatology (Hoboken, N.J.)

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Cecilia Hemgren, Klara Martinsson, Christopher Rooney, Jonas Wetterö, Kulveer Mankia, Paul Emery, Alf Kastbom
Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody-Positive At-Risk Individuals Without Arthritis. The Journal of rheumatology 51 (2) (2024)
Samantha Gascoyne, Andrew Mott, Katie Carlisle, Abhishek Abhishek, Joy Adamson, Laura C Coates, Bernard van Duren, Paul Emery, Susan Marion Goodman, Catherine Hewitt, Jinshuo Li, Laura Mandefield, Gillian Parkinson, Helena Marzo-Ortega, James Maxwell, Jagdeep Nanchahal, Amar Rangan, Duncan Richards, Sarah Ronaldson, Susan Shepherd, Johanna Taylor, Jeremy Mark Wilkinson, Hemant Pandit, Kulveer Singh Mankia
PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) - a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study. BMJ open 14 (6) (2024)
Or Hen, Andrea Di Matteo, Sayam R Dubash, Gabriele de Marco, Ai Lyn Tan, Paul Emery, Richard J Wakefield, Dennis G McGonagle, Philip S Helliwell, Stephanie Rose Harrison
High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort. RMD open 10 (2) (2024)
Hanna Gul, Andrea Di Matteo, Innocent Chidi Anioke, Farag Shuweidhi, Kulveer Mankia, Frederique Ponchel, Paul Emery
Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy. ACR open rheumatology 6 (5) (2024)
Kevin D Deane, V Michael Holers, Paul Emery, Kulveer Mankia, Hani El Gabalawy, Jeffrey A Sparks, Karen H Costenbader, Larissa Valor-Méndez, Annette van der Helm-van Mil, Dirkjan van Schaardenburg, Ranjeny Thomas, Andrew P Cope
Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease. Annals of the rheumatic diseases (2024)
Andrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, Sana Sharrack, Laurence Duquenne, Jacqueline L Nam, Michael Mahler, Paul Emery
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD open 10 (2) (2024)
Andrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, Sana Sharrack, Laurence Duquenne, Jacqueline L Nam, Michael Mahler, Paul Emery
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD open 10 (2) (2024)
Hanna Gul, Andrea Di Matteo, Innocent Chidi Anioke, Farag Shuweidhi, Kulveer Mankia, Frederique Ponchel, Paul Emery
Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy. ACR open rheumatology 6 (5) (2024)
Samantha Gascoyne, Andrew Mott, Katie Carlisle, Abhishek Abhishek, Joy Adamson, Laura C Coates, Bernard van Duren, Paul Emery, Susan Marion Goodman, Catherine Hewitt, Jinshuo Li, Laura Mandefield, Gillian Parkinson, Helena Marzo-Ortega, James Maxwell, Jagdeep Nanchahal, Amar Rangan, Duncan Richards, Sarah Ronaldson, Susan Shepherd, Johanna Taylor, Jeremy Mark Wilkinson, Hemant Pandit, Kulveer Singh Mankia
PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) - a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study. BMJ open 14 (6) (2024)
Or Hen, Andrea Di Matteo, Sayam R Dubash, Gabriele de Marco, Ai Lyn Tan, Paul Emery, Richard J Wakefield, Dennis G McGonagle, Philip S Helliwell, Stephanie Rose Harrison
High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort. RMD open 10 (2) (2024)
Andrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, Sana Sharrack, Laurence Duquenne, Jacqueline L Nam, Michael Mahler, Paul Emery
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD open 10 (2) (2024)
Cecilia Hemgren, Klara Martinsson, Christopher Rooney, Jonas Wetterö, Kulveer Mankia, Paul Emery, Alf Kastbom
Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody-Positive At-Risk Individuals Without Arthritis. The Journal of rheumatology 51 (2) (2024)
Or Hen, Andrea Di Matteo, Sayam R Dubash, Gabriele de Marco, Ai Lyn Tan, Paul Emery, Richard J Wakefield, Dennis G McGonagle, Philip S Helliwell, Stephanie Rose Harrison
High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort. RMD open 10 (2) (2024)
Hanna Gul, Andrea Di Matteo, Innocent Chidi Anioke, Farag Shuweidhi, Kulveer Mankia, Frederique Ponchel, Paul Emery
Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy. ACR open rheumatology (2024)
Hanna Gul, Andrea Di Matteo, Innocent Chidi Anioke, Farag Shuweidhi, Kulveer Mankia, Frederique Ponchel, Paul Emery
Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy. ACR open rheumatology 6 (5) (2024)
Cecilia Hemgren, Klara Martinsson, Christopher Rooney, Jonas Wetterö, Kulveer Mankia, Paul Emery, Alf Kastbom
Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody-Positive At-Risk Individuals Without Arthritis. The Journal of rheumatology 51 (2) (2024)
Andrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, Sana Sharrack, Laurence Duquenne, Jacqueline L Nam, Michael Mahler, Paul Emery
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD open 10 (2) (2024)
Or Hen, Andrea Di Matteo, Sayam R Dubash, Gabriele de Marco, Ai Lyn Tan, Paul Emery, Richard J Wakefield, Dennis G McGonagle, Philip S Helliwell, Stephanie Rose Harrison
High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort. RMD open 10 (2) (2024)
Samantha Gascoyne, Andrew Mott, Katie Carlisle, Abhishek Abhishek, Joy Adamson, Laura C Coates, Bernard van Duren, Paul Emery, Susan Marion Goodman, Catherine Hewitt, Jinshuo Li, Laura Mandefield, Gillian Parkinson, Helena Marzo-Ortega, James Maxwell, Jagdeep Nanchahal, Amar Rangan, Duncan Richards, Sarah Ronaldson, Susan Shepherd, Johanna Taylor, Jeremy Mark Wilkinson, Hemant Pandit, Kulveer Singh Mankia
PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) - a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study. BMJ open 14 (6) (2024)
Andrea Di Matteo, Kulveer Mankia, Leticia Garcia-Montoya, Sana Sharrack, Laurence Duquenne, Jacqueline L Nam, Michael Mahler, Paul Emery
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD open 10 (2) (2024)
Heidi J Siddle, Stephen Henry Bradley, Anna M Anderson, Kulveer Mankia, Paul Emery, Suzanne H Richards
Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice. The British journal of general practice : the journal of the Royal College of General Practitioners 73 (729) (2023)
Paula David, Andrea Di Matteo, Or Hen, Shouvik Dass, Helena Marzo-Ortega, Richard J Wakefield, Leslie-Anne Bissell, Jacqueline Nam, Kulveer Mankia, Paul Emery, Benazir Saleem, Dennis McGonagle
Poly-refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease with Distinct Inflammatory and Non-inflammatory Phenotypes. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Innocent Chidi Anioke, Laurence Duquenne, Rekha Parmar, Kulveer Mankia, Farag Shuweihdi, Paul Emery, Frederique Ponchel
Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals. Rheumatology (Oxford, England) (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Thomas W J Huizinga, Gustavo Citera, Clifton O Bingham, Subhashis Banerjee, Benjamin P Soule, Marleen Nys, Sean E Connolly, Karissa L Lozenski, Joe Zhuo, Robert Wong, Kuan-Hsiang Gary Huang, Roy Fleischmann
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis. Rheumatology and therapy (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Eric L Matteson, Marco Matucci Cerinic, Michael Kreuter, Gerd-Rüdiger R Burmester, Philippe Dieude, Paul Emery, Yannick Allanore, Janet E Pope, Dinesh Khanna
Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review. RMD open 9 (3) (2023)
Elena Pontarini, E Sciacca, F Chowdhury, S Grigoriadou, F Rivellese, W J Murray-Brown, Davide Lucchesi, L Fossati-Jimack, A Nerviani, Wlodzimierz J Krzyzosiak, G M Ghirardi, C Giacomassi, Paul Emery, W F Ng, N Sutcliffe, Colin C Everett, C Fernandez, A R Tappuni, R Seror, X Mariette, R Porcher, G Cavallaro, A Pulvirenti, Gwenny M Verstappen, Lisette de Wolff, S Arends, H Bootsma, Myles J Lewis, Costantino Pitzalis, S J Bowman, M Bombardieri, null null
Serum and tissue biomarkers associated with CRESS and STAR response to B-cell targeted therapy in TRACTISS trial of Sjogren's syndrome. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Heidi J Siddle, Stephen Henry Bradley, Anna M Anderson, Kulveer Mankia, Paul Emery, Suzanne H Richards
Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice. The British journal of general practice : the journal of the Royal College of General Practitioners 73 (729) (2023)
Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? Annals of the rheumatic diseases (2023)
Jeffrey R Curtis, Paul Emery, Bryan Downie, Yan Zhong, Jinfeng Liu, Ling Han, Rachael E Hawtin, Gerd-Rüdiger R Burmester
Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis. Rheumatology and therapy (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Heidi J Siddle, Stephen Henry Bradley, Anna M Anderson, Kulveer Mankia, Paul Emery, Suzanne H Richards
Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice. The British journal of general practice : the journal of the Royal College of General Practitioners 73 (729) (2023)
Laurence Duquenne, Elizabeth M A Hensor, Michelle Wilson, Leticia Garcia-Montoya, Jacqueline L Nam, Jianhua Wu, Kate Harnden, Innocent Chidi Anioke, Andrea Di Matteo, Rahaymin Chowdhury, Navkiran Sidhu, Frederique Ponchel, Kulveer Mankia, Paul Emery
Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification. Annals of internal medicine (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Elena Myasoedova, Arjun P Athreya, Cynthia S Crowson, John M Davis, Kenneth J Warrington, Robert C Walchak, Erin Carlson, Krishna R Kalari, Tim Bongartz, Paul P Tak, Ronald F van Vollenhoven, Leonid Padyukov, Paul Emery, Ann W Morgan, Liewei Wang, Richard M Weinshilboum, Eric L Matteson, null null
Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach. Arthritis care & research 74 (6) (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine (2022)
Lotte van Ouwerkerk, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Patrick Verschueren, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Benazir Saleem, Rebecca L Ross, Lesley-Anne Bissell, Aamir Aslam, Kulveer Mankia, Laurence Duquenne, Diane Corsadden, Clive Carter, Pam Hughes, Fatima A Nadat, Panji Mulipa, Mark Lobb, Brendan Clarke, Katie Mbara, Ruth Morton, Sophie Dibb, Rahaymin Chowdhury, Darren Newton, Alexandra Pike, Vishal Kakkar, Sinisia Savic, Francesco DelGaldo, Paul Emery
Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses. RMD open 8 (1) (2022)
Daniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, Christian Dejaco, Maxime Dougados, Iain B McInnes, Naveed Sattar, Tanja Alexandra Stamm, Tsutomu Takeuchi, Michael Trauner, Désirée Mfm van der Heijde, Marieke Voshaar, Kevin L Winthrop, Angelo Ravelli, Neil Betteridge, Gerd-Rüdiger R Burmester, Johannes W J Bijlsma, Vivian Bykerk, Roberto Caporali, Ernest H S Choy, Catalin Codreanu, Bernard Combe, Mary K Crow, Maarten P T de Wit, Paul Emery, Roy M Fleischmann, Cem Gabay, Merete Lund Hetland, Kimmie L Hyrich, AnnaMaria Iagnocco, John Dudley Isaacs, Joel M Kremer, Xavier Mariette, Peter A Merkel, Eduardo F Mysler, Peter Nash, Michael T Nurmohamed, Karel Pavelka, Gyula Poor, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Anja Strangfeld, Yoshiya Tanaka, Josef S Smolen
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the rheumatic diseases (2022)
Sophanit Pepple, Jack Arnold, Edward M Vital, Andrew C Rawstron, Colin T Pease, Shouvik Dass, Paul Emery, Md Yuzaiful Md Yusof
Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome. ACR open rheumatology 4 (8) (2022)
John Fitton, Andrew Melville, Kamran Naraghi, Jacqueline Nam, Shouvik Dass, Paul Emery, Maya H Buch
Single-centre experience of refractory rheumatoid arthritis. Rheumatology advances in practice 6 (2) (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Frederique Ponchel, Laurence Duquenne, Xuanxiao Xie, Diane Corscadden, Farag Shuweihdi, Kulveer Mankia, L A Trouw, Paul Emery
Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals. RMD open 8 (2) (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Leticia Garcia-Montoya, Jacqueline L Nam, Laurence Duquenne, Catalina Villota-Eraso, Andrea Di Matteo, Collette Hartley, Kulveer Mankia, Paul Emery
Prioritising referrals of individuals at-risk of RA: guidance based on results of a 10-year national primary care observational study. Arthritis research & therapy 24 (1) (2022)
Frederique Ponchel, Laurence Duquenne, Xuanxiao Xie, Diane Corscadden, Farag Shuweihdi, Kulveer Mankia, L A Trouw, Paul Emery
Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals. RMD open 8 (2) (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Frederique Ponchel, Laurence Duquenne, Xuanxiao Xie, Diane Corscadden, Farag Shuweihdi, Kulveer Mankia, L A Trouw, Paul Emery
Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals. RMD open 8 (2) (2022)
John D Biglands, Bara Erhayiem, Graham Fent, John P Greenwood, Raluca B Dumitru, Jacqueline Andrews, Paul Emery, Maya H Buch, Sven Plein
No differences in myocardial perfusion between treatment-naive, early rheumatoid arthritis patients and healthy controls. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Lucy Marie Carter, Adewonuola Alase, Zoe Wigston, Antony Psarras, Agata Burska, Emily Sutton, Md Yuzaiful Md Yusof, John A Reynolds, null null, Neil McHugh, Paul Emery, Miriam Wittmann, Ian N Bruce, Edward M Vital
Gene expression and autoantibody analysis reveals distinct ancestry-specific profiles associated with response to rituximab in refractory systemic lupus erythematosus. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Leticia Garcia-Montoya, Paul Emery
Disease modification in ankylosing spondylitis with TNF inhibitors: spotlight on early phase clinical trials. Expert opinion on investigational drugs (2021)
John Fitton, Andrew R Melville, Paul Emery, Jacqueline L Nam, Maya H Buch
Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway. Rheumatology (Oxford, England) 60 (9) (2021)
Christopher M Rooney, Kulveer Mankia, Suparna Mitra, Ines B Moura, Paul Emery, Mark H Wilcox
Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis. Rheumatology (Oxford, England) 60 (7) (2021)
Fenne Wouters, Marc P Maurits, Laurette van Boheemen, Marloes Verstappen, Kulveer Mankia, Xanthe Marijn Edmée Matthijssen, Annemarie L Dorjée, Paul Emery, Rachel Knevel, Dirkjan van Schaardenburg, René E M Toes, Annette H M van der Helm van Mil
Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis. Annals of the rheumatic diseases (2021)
Sayam R Dubash, Oras A Alabas, Xabier Michelena, Leticia Garcia-Montoya, Richard J Wakefield, Philip S Helliwell, Paul Emery, Dennis G McGonagle, Ai Lyn Tan, Helena Marzo-Ortega
Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis. Annals of the rheumatic diseases (2021)
Heidi J Siddle, Lara S Chapman, Kulveer Mankia, Codruța Zăbălan, Marios Kouloumas, Karim Raza, Marie Falahee, Joel Kerry, Andreas Kerschbaumer, Daniel Aletaha, Paul Emery, Suzanne H Richards
Perceptions and experiences of individuals at-risk of rheumatoid arthritis (RA) knowing about their risk of developing RA and being offered preventive treatment: systematic review and thematic synthesis of qualitative studies. Annals of the rheumatic diseases (2021)
Kulveer Mankia, Heidi Siddle, Andrea Di Matteo, Deshiré Alpizar-Rodriguez, Joel Kerry, Andreas Kerschbaumer, Daniel Aletaha, Paul Emery
A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. RMD open 7 (3) (2021)
Andrew R Melville, Md Yuzaiful Md Yusof, John Fitton, Leticia Garcia-Montoya, Lynda Bailey, Shouvik Dass, Paul Emery, Maya H Buch, Benazir Saleem
Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis. Rheumatology (Oxford, England) 60 (8) (2021)
Stephanie Rose Harrison, Agata N Burska, Paul Emery, Helena Marzo-Ortega, Frederique Ponchel
Interferon-related gene expression in response to TNF inhibitor treatment in ankylosing spondylitis patients: a pilot study. Rheumatology (Oxford, England) 60 (8) (2021)
Josef S Smolen, Jung-Yoon Choe, Michael E Weinblatt, Paul Emery, Edward Keystone, Mark C Genovese, Gihyun Myung, Evelyn Hong, Inyoung Baek, Jeehoon Ghil
Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis. RMD open 6 (1) (2021)
Khaled Mahmoud, Ahmed S Zayat, Md Yuzaiful Md Yusof, Katherine Dutton, Lee Suan Teh, Chee-Seng Yee, David D'Cruz, Nora Ng, David Alan Isenberg, Coziana Ciurtin, Philip G Conaghan, Paul Emery, Christopher J Edwards, Elizabeth M A Hensor, Edward M Vital
Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study. Rheumatology (Oxford, England) 60 (11) (2021)
Sayam R Dubash, Oras A Alabas, Xabier Michelena, Leticia Garcia-Montoya, Gabriele de Marco, Mira Merashli, Richard J Wakefield, Paul Emery, Dennis McGonagle, Ai Lyn Tan, Helena Marzo-Ortega
Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-naïve early psoriatic arthritis. Rheumatology advances in practice 5 (3) (2021)
Jeffrey R Curtis, Paul Emery, Elaine Karis, Boulos Haraoui, Vivian P Bykerk, Priscilla K Yen, Greg Kricorian, James B Chung
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission. Arthritis & rheumatology (Hoboken, N.J.) 73 (5) (2021)
Jack Arnold, Kevin Winthrop, Paul Emery
COVID-19 vaccination and antirheumatic therapy. Rheumatology (Oxford, England) 60 (8) (2021)
Kulveer Mankia, Heidi J Siddle, Andreas Kerschbaumer, Deshiré Alpizar-Rodriguez, Anca Irinel Catrina, Juan D Cañete, Andrew P Cope, Claire Immediato Daien, Kevin D Deane, Hani El Gabalawy, Axel Finckh, V Michael Holers, Marios Koloumas, Francesca Ometto, Karim Raza, Condruta Zabalan, Annette H M van der Helm van Mil, Dirkjan van Schaardenburg, Daniel Aletaha, Paul Emery
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. Annals of the rheumatic diseases 80 (10) (2021)
Andrea Di Matteo, Kulveer Mankia, Jacqueline L Nam, Edoardo Cipolletta, Leticia Garcia-Montoya, Laurence Duquenne, Emma Rowbotham, Paul Emery
In anti-CCP+ at-risk individuals, radiographic bone erosions are uncommon and are not associated with the development of clinical arthritis. Rheumatology (Oxford, England) 60 (7) (2021)
HoUng Kim, Rieke E Alten, J R Fraser Cummings, Silvio Danese, Geert R A M D'Haens, Paul Emery, Subrata Ghosh, Cyrielle Gilletta de Saint Joseph, Jong Hyuk Lee, James O Lindsay, Elena Nikiphorou, Ben Parker, Stefan Schreiber, Steven R A Simoens, René Westhovens, Ji Hoon Jeong, Laurent Peyrin-Biroulet
Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters. mAbs 13 (1) (2021)
Md Yuzaiful Md Yusof, Edward M Vital, Paul Emery, Sinisa Savic
Reply. Arthritis & rheumatology (Hoboken, N.J.) 72 (7) (2020)
Harris A Ahmad, Joshua F Baker, Mikkel Østergaard, Paul Emery, Patrick Durez, June Ye, Subhashis Banerjee, Philip Gerard Conaghan
Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor Prognosis. Arthritis care & research 72 (7) (2020)
Paul Emery, Hubert van Hoogstraten, Karthinathan Thangavelu, Erin Mangan, Gregory St John, Patrick Verschueren
Subcutaneous Sarilumab in Patients With Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open-Label Extension of a Randomized Clinical Trial. ACR open rheumatology 2 (11) (2020)
Frederique Ponchel, Agata N Burska, Laura Hunt, Hanna Gul, Thibault Rabin, Rekha Parmar, Maya H Buch, Philip Gerard Conaghan, Paul Emery
T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management. Scientific reports 10 (1) (2020)
Peter Nash, Andreas Kerschbaumer, Thomas Dörner, Maxime Dougados, Roy M Fleischmann, Klaus Geissler, Iain McInnes, Janet E Pope, Désirée Mfm van der Heijde, Michaela Stoffer-Marx, Tsutomu Takeuchi, Michael Trauner, Kevin L Winthrop, Maarten P T de Wit, Daniel Aletaha, Xenofon Baraliakos, Wolf-Henning Boehncke, Paul Emery, John D Isaacs, Joel Kremer, Eun Bong Lee, Walter P Maksymowych, Marieke Voshaar, Lai-Shan Tam, Yoshiya Tanaka, Filip van den Bosch, René Westhovens, Ricardo Xavier, Josef S Smolen
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Annals of the rheumatic diseases 80 (1) (2020)
Andrea Di Matteo, Kulveer Mankia, Laurence Duquenne, Edoardo Cipolletta, Richard J Wakefield, Leticia Garcia-Montoya, Jacqueline Leong Nam, Paul Emery
Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis. Annals of the rheumatic diseases 79 (7) (2020)
Andrea Di Matteo, Kulveer Mankia, Laurence Duquenne, Michael Mahler, Diane Corscadden, Katie Mbara, Leticia Garcia-Montoya, Jacqueline L Nam, Paul Emery
Third-Generation Anti-Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 72 (11) (2020)
Yasser Mohamed El-Sherbiny, Md Yuzaiful Md Yusof, Antonios Psarras, Elizabeth M A Hensor, Kumba Z Kabba, Katherine Dutton, Alaa A A Mohamed, Dirk Elewaut, Dennis McGonagle, Reuben Tooze, Gina Doody, Miriam Wittmann, Paul Emery, Edward M Vital
B Cell Tetherin: A Flow Cytometric Cell-Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus. Arthritis & rheumatology (Hoboken, N.J.) 72 (5) (2020)
Paul Emery, Gerd R Burmester, Esperanza Naredo, Luigi Sinigaglia, Ivan Lagunes, Franziska Koenigsbauer, Philip Gerard Conaghan
Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Annals of the rheumatic diseases 79 (8) (2020)
Josef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B McInnes, Alexandre Sepriano, Ronald F van Vollenhoven, Maarten P T de Wit, Daniel Aletaha, Martin Aringer, John Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Mario Humberto Cardiel, Diederik De Cock, Catalin Codreanu, Maurizio Cutolo, Christopher John Edwards, Yvonne van Eijk-Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques-Eric Gottenberg, Merete Lund Hetland, Thomas Wj Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller-Ladner, Eduardo F Mysler, José António Pereira Da Silva, Gyula Poór, Janet E Pope, Andrea Rubbert-Roth, Adeline Ruyssen-Witrand, Kenneth G Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the rheumatic diseases 79 (6) (2020)
Antonios Psarras, Adewonuola Alase, Agne Antanaviciute, Ian M Carr, Md Yuzaiful Md Yusof, Miriam Wittmann, Paul Emery, George C Tsokos, Edward M Vital
Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity. Nature communications 11 (1) (2020)
Zijian Cheng, Thuy Do, Kulveer Mankia, Josephine Meade, Laura Hunt, Val Clerehugh, Alastair Speirs, Aradhna Tugnait, Paul Emery, Deirdre Ann Devine
Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis. Annals of the rheumatic diseases 80 (2) (2020)
Andrea Di Matteo, Kulveer Mankia, Richard J Wakefield, Paul Emery
Which joints and what pathological findings should be evaluated on ultrasound in CCP+ at-risk individuals? The fifth MTP joint for bone erosions is a good starting point. Response to: 'Pisotriquetral arthritis: 'forgotten' joint in ultrasound imaging of the wrist' by Becciolini et al. Annals of the rheumatic diseases (2020)
Sven Plein, Bara Erhayiem, Graham Fent, Sarah Horton, Raluca Bianca Dumitru, Jacqueline Andrews, John P Greenwood, Paul Emery, Elizabeth Ma Hensor, Paul Baxter, Sue Pavitt, Maya H Buch
Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis. Annals of the rheumatic diseases 79 (11) (2020)
Paul Emery, Sarah Horton, Raluca Bianca Dumitru, Kamran Naraghi, Désirée Mfm van der Heijde, Richard J Wakefield, Elizabeth M A Hensor, Maya H Buch
Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial. Annals of the rheumatic diseases 79 (4) (2020)
Kulveer Mankia, Paul Emery
Palindromic rheumatism as part of the rheumatoid arthritis continuum. Nature reviews. Rheumatology 15 (11) (2019)
Md Yuzaiful Md Yusof, Edward M Vital, Damien M McElvenny, Elizabeth M A Hensor, Sudipto Das, Shouvik Dass, Andy C Rawstron, Maya H Buch, Paul Emery, Sinisa Savic
Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases. Arthritis & rheumatology (Hoboken, N.J.) 71 (11) (2019)
Philip S Helliwell, Laura C Coates, Ne Siang Chew, Giovanni Lettieri, Anna R Moverley, Jane E Freeston, Jacqueline L Nam, Robin Waxman, Paul Emery, Philip Gerard Conaghan
Comparing Psoriatic Arthritis Low-field Magnetic Resonance Imaging, Ultrasound, and Clinical Outcomes: Data from the TICOPA Trial. The Journal of rheumatology 47 (9) (2019)
Graham Fent, Kulveer Mankia, Bara Erhayiem, Laura Hunt, Jacqueline Leong Nam, Lesley-Anne Bissell, James Rj Foley, Pei G Chew, Louise E Brown, John P Greenwood, Paul Emery, Sven Plein, Maya H Buch
First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis. Annals of the rheumatic diseases 78 (8) (2019)
Kulveer Mankia, Christopher Briggs, Paul Emery
How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies-positive Patients Who Do Not Have Arthritis? The Journal of rheumatology 47 (2) (2019)
Jonathan Kay, Thomas Dörner, Paul Emery, Tore K Kvien, Ferdinand C Breedveld
Clinical trial and 'real-world' data support switching from a bio-originator to its biosimilar. Annals of the rheumatic diseases 79 (4) (2019)
Phillip J Mease, Josef S Smolen, Frank Behrens, Peter Nash, Soyi Liu Leage, Lingnan Li, Hasan Tahir, Melinda Gooderham, Eswar Krishnan, Hong Liu-Seifert, Paul Emery, Sreekumar G Pillai, Philip S Helliwell, null null
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Annals of the rheumatic diseases 79 (1) (2019)
Paul Emery, Bonnie Vlahos, Piotr Szczypa, Mazhar Thakur, Heather E Jones, John Woolcott, Paul V Santos Estrella, Catherine Rolland, Allan Gibofsky, Gustavo Citera, Sargunan Sockalingam, Lisa Marshall
Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis. The Journal of rheumatology 47 (4) (2019)
Kulveer Mankia, Maria-Antonietta D'Agostino, Emma Rowbotham, Elizabeth Ma Hensor, Laura Hunt, Ingrid Möller, Misabel Miguel, José Ramon Mérida-Velasco, Jorge Murillo-González, Esperanza Naredo, Jacqueline Leong Nam, Ai Lyn Tan, Jane E Freeston, Andrew Grainger, Paul Emery
MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis. Annals of the rheumatic diseases 78 (6) (2019)
Kulveer Mankia, Maria-Antonietta D'Agostino, Jorge Murillo-González, Andrew Grainger, Paul Emery
Response to: 'Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?' by Deng et al. Annals of the rheumatic diseases 79 (7) (2019)
Laura C Coates, Ennio Lubrano, Fabio Massimo Perrotta, Paul Emery, Philip Gerard Conaghan, Philip S Helliwell
What Should Be the Primary Target of "Treat to Target" in Psoriatic Arthritis? The Journal of rheumatology 46 (1) (2018)